223 related articles for article (PubMed ID: 18937120)
1. HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
Puri A; Kramer-Marek G; Campbell-Massa R; Yavlovich A; Tele SC; Lee SB; Clogston JD; Patri AK; Blumenthal R; Capala J
J Liposome Res; 2008; 18(4):293-307. PubMed ID: 18937120
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).
Smith B; Lyakhov I; Loomis K; Needle D; Baxa U; Yavlovich A; Capala J; Blumenthal R; Puri A
J Control Release; 2011 Jul; 153(2):187-94. PubMed ID: 21501640
[TBL] [Abstract][Full Text] [Related]
3. A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells.
Yavlovich A; Singh A; Blumenthal R; Puri A
Biochim Biophys Acta; 2011 Jan; 1808(1):117-26. PubMed ID: 20691151
[TBL] [Abstract][Full Text] [Related]
4. Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models.
Alavizadeh SH; Akhtari J; Badiee A; Golmohammadzadeh S; Jaafari MR
Expert Opin Drug Deliv; 2016; 13(3):325-36. PubMed ID: 26578208
[TBL] [Abstract][Full Text] [Related]
5. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
6. Polar Lipid Fraction E from
Ayesa U; Chong PL
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182284
[TBL] [Abstract][Full Text] [Related]
7. Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors.
Akhtari J; Rezayat SM; Teymouri M; Alavizadeh SH; Gheybi F; Badiee A; Jaafari MR
Int J Pharm; 2016 May; 505(1-2):89-95. PubMed ID: 27039149
[TBL] [Abstract][Full Text] [Related]
8. Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes.
Novell A; Al Sabbagh C; Escoffre JM; Gaillard C; Tsapis N; Fattal E; Bouakaz A
Int J Hyperthermia; 2015 Jun; 31(4):349-58. PubMed ID: 25677841
[TBL] [Abstract][Full Text] [Related]
9. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
Shishido T; Mieda H; Hwang SY; Nishimura Y; Tanaka T; Ogino C; Fukuda H; Kondo A
Bioorg Med Chem Lett; 2010 Oct; 20(19):5726-31. PubMed ID: 20801029
[TBL] [Abstract][Full Text] [Related]
10. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of thermosensitive poly(N-(2-hydroxypropyl) methacrylamide mono/dilactate)-grafted liposomes for cancer thermochemotherapy.
van Elk M; van den Dikkenberg JB; Storm G; Hennink WE; Vermonden T; Heger M
Int J Pharm; 2018 Oct; 550(1-2):190-199. PubMed ID: 30130606
[TBL] [Abstract][Full Text] [Related]
12. Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL).
Beuttler J; Rothdiener M; Müller D; Frejd FY; Kontermann RE
Bioconjug Chem; 2009 Jun; 20(6):1201-8. PubMed ID: 19435362
[TBL] [Abstract][Full Text] [Related]
13. Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules.
Perols A; Honarvar H; Strand J; Selvaraju R; Orlova A; Karlström AE; Tolmachev V
Bioconjug Chem; 2012 Aug; 23(8):1661-70. PubMed ID: 22768790
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of an anti-cancer agent via steroid coupled liposomes.
Mishra PK; Gulbake A; Jain A; Vyas SP; Jain SK
Drug Deliv; 2009 Nov; 16(8):437-47. PubMed ID: 19839788
[TBL] [Abstract][Full Text] [Related]
15. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
[TBL] [Abstract][Full Text] [Related]
16. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
[TBL] [Abstract][Full Text] [Related]
17. A two-component drug delivery system using Her-2-targeting thermosensitive liposomes.
Kullberg M; Mann K; Owens JL
J Drug Target; 2009 Feb; 17(2):98-107. PubMed ID: 19089689
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules.
Ahlgren S; Orlova A; Rosik D; Sandström M; Sjöberg A; Baastrup B; Widmark O; Fant G; Feldwisch J; Tolmachev V
Bioconjug Chem; 2008 Jan; 19(1):235-43. PubMed ID: 18163536
[TBL] [Abstract][Full Text] [Related]
19. Characterization and cytotoxicity studies of DPPC:M(2+) novel delivery system for cisplatin thermosensitivity liposome with improving loading efficiency.
Liu H; Zhang Y; Han Y; Zhao S; Wang L; Zhang Z; Wang J; Cheng J
Colloids Surf B Biointerfaces; 2015 Jul; 131():12-20. PubMed ID: 25938850
[TBL] [Abstract][Full Text] [Related]
20. Active uptake of drugs into photosensitive liposomes and rapid release on UV photolysis.
Bisby RH; Mead C; Morgan CG
Photochem Photobiol; 2000 Jul; 72(1):57-61. PubMed ID: 10911729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
